Department of Obstetrics and Gynecology, Shiga University of Medical Science.
Tohoku J Exp Med. 2013 Dec;231(4):243-50. doi: 10.1620/tjem.231.243.
Adult-type granulosa cell tumor (AGCT) is a rare class of malignant ovarian tumor with unique features, characterized by slow growth, late recurrence, relatively good prognosis and unified cause in almost all patients. The forkhead box L2 (FOXL2) gene encodes an essential transcription factor in the ovary. FOXL2 is important in female sex determination, follicle recruitment, and granulosa cell development. About 70-97% of AGCTs were reported to carry a somatic mutation c.402C>G (C134W) in the FOXL2 gene. However, it is unknown whether AGCTs of Japanese patients harbor the FOXL2 c.402C>G mutation. Here, we report a mutational analysis of the FOXL2 gene in four Japanese patients with AGCTs, and we review the literature to determine the precise incidence of FOXL2 mutations in AGCTs. All four patients were analyzed by immunohistochemistry for FOXL2. Genomic DNA was extracted from paraffin-embedded tissues, and was analyzed to detect the c.402C>G mutation in FOXL2 by direct sequencing. All tumors were stained with FOXL2. Three of the four tumors harbor the c.402C>G mutation. Based on the literature review, FOXL2 immunostaining is a highly specific marker for sex cord-stromal tumors (SCSTs), but it is not specific for AGCTs, one subtype of SCSTs. We identified 340 patients with the FOXL2 mutation (c.402C>G) and determined that the incidence of the mutation is 91.9% in AGCT patients. Therefore, this FOXL2 mutation is specific to AGCTs in the ovary and is useful for diagnosis of this disease.
成人型颗粒细胞瘤(AGCT)是一种罕见的卵巢恶性肿瘤,具有独特的特征,其生长缓慢,复发较晚,预后相对较好,几乎所有患者的病因都相同。叉头框 L2(FOXL2)基因编码卵巢中必需的转录因子。FOXL2 在女性性别决定、卵泡募集和颗粒细胞发育中起重要作用。据报道,约 70-97%的 AGCT 携带 FOXL2 基因中的体细胞突变 c.402C>G(C134W)。然而,目前尚不清楚日本患者的 AGCT 是否携带 FOXL2 c.402C>G 突变。在此,我们报告了 4 例日本 AGCT 患者 FOXL2 基因突变的分析,并对文献进行了回顾,以确定 FOXL2 突变在 AGCT 中的确切发生率。所有 4 例患者均进行 FOXL2 免疫组化分析。从石蜡包埋组织中提取基因组 DNA,并通过直接测序分析 FOXL2 中 c.402C>G 突变。所有肿瘤均用 FOXL2 染色。4 例肿瘤中有 3 例携带 c.402C>G 突变。根据文献回顾,FOXL2 免疫组化是性索-间质肿瘤(SCSTs)的高度特异性标志物,但对 AGCT 不是特异性的,AGCT 是 SCSTs 的一个亚型。我们确定了 340 例 FOXL2 突变(c.402C>G)患者,并确定该突变在 AGCT 患者中的发生率为 91.9%。因此,这种 FOXL2 突变是卵巢 AGCT 的特异性标志物,对该病的诊断具有重要意义。